TO EVALUATE THE EFFICIENCY AND SAFETY OF PRUTNYAK IN THE TREATMENT OF HYPERPROLACTINEMIA
Main Article Content
Hyperprolactinemia (HPRL) has a significant impact on the health and quality of life of patients. As a result, patients often stop taking medications, which worsens the prognosis of the disease. Thus, managing HPPD during treatment has become a challenge for clinicians.
How to Cite
Oltieva Malohat. (2022). TO EVALUATE THE EFFICIENCY AND SAFETY OF PRUTNYAK IN THE TREATMENT OF HYPERPROLACTINEMIA. Archive of Conferences, 171-172. Retrieved from https://conferencepublication.com/index.php/aoc/article/view/2204
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.